Femasys Inc. (FEMY)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Femasys Inc. (FEMY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.21 per share a year ago.
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
Femasys Inc. (FEMY) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.17 per share a year ago.
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates
Femasys Inc. (FEMY) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.19 per share a year ago.
Femasys Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| WTM W. Travis McKinney HB Wealth Management LLC | 555.9 | $3,917.98 | $1,923.41 | -$1,994.57 | -50.91% |
 Matthew Okkerse Dauntless Investment Group LLC | 301,651.5 | $4.42M | $950,202.22 | -$3.47M | -78.48% |
 Stephen A. Greco Pandora Wealth Inc. | 750 | $18,750 | $2,362.5 | -$16,387.5 | -87.4% |
 Heather Scully NWF Advisory Services Inc. | 2,352.75 | $51,289.95 | $7,258.23 | -$44,031.72 | -85.85% |
| GWM Gibbs Wealth Management Gibbs Wealth Management | 605 | $5,083.81 | $1,781.72 | -$3,302.09 | -64.95% |
Femasys Inc. (FEMY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Femasys Inc. ever had a stock split?
Femasys Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Kathy Lee-Sepsick CEO | NASDAQ (CM) Exchange | 31447E204 CUSIP |
| US Country | 54 Employees | - Last Dividend | 8 Jun 2026 Last Split | 18 Jun 2021 IPO Date |
Overview
Femasys Inc. is a forward-thinking biomedical company that plays a significant role in pioneering advancements within the women's healthcare sector, both in the United States and internationally. Established in 2004, with its headquarters located in Suwanee, Georgia, Femasys Inc. has dedicated itself to developing innovative solutions aimed at addressing a variety of needs in women's healthcare. Their efforts are encompassed in creating devices and procedures that span infertility treatments, cervical health assessments, and non-surgical alternatives for common women’s health issues.
Products and Services
- FemVue Saline-Air Device: This device is a novel contrast-generating product that is used for sonography in the United States, Canada, Japan, and Hong Kong. It facilitates the evaluation of fallopian tubal patency in women who are assessing their fertility options or facing infertility challenges.
- FemCath Cornual Balloon Catheter: As a unique intrauterine directional delivery product, FemCath allows for the selective evaluation of an individual fallopian tube, providing valuable insights for fertility assessments and treatments.
- FemCerv Endocervical Curettage Device: This biopsy device is designed for the extraction of endocervical tissue. It allows circumferential sampling of cervical cells and ensures sample containment within the device to minimize contamination, enhancing the accuracy of cervical health assessments.
- FemBloc & FemChec: These products represent Femasys Inc.’s venture into permanent birth control solutions, offering women non-surgical alternatives to traditional sterilization methods.
- FemaSeed Artificial Insemination: A noteworthy development in assisted reproduction, FemaSeed provides an innovative approach to artificial insemination, supporting women and couples in their journey towards parenthood.
- FemEMB: This product candidate is under development for endometrial sampling. It supports uterine cancer detection testing by allowing for efficient and minimally invasive sampling of the endometrium.
Femasys Inc.’s suite of products and services is primarily aimed at obstetricians-gynecologists (OB-GYNs), reproductive endocrinologists, and other healthcare professionals specialized in women’s health. By providing a broad range of devices that cater to various aspects of women’s healthcare, the company fills a critical gap in the market, ensuring that women have access to efficient, innovative, and less invasive healthcare solutions.
